7th Pharmacovigilance 2014
Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management. 21st November 2014, Kohinoor Continental Hotel, Mumbai, India.
- (1888PressRelease) November 21, 2014 - Get more from the event, with a broader scope bringing the whole communications value chain together.
Key Themes Discussed at this Summit:
- Improving patient care and safety in relation to use of medicines and all medical and paramedical interventions
- Identifying the latest regulatory framework for pharmacovigilance
- Crisis management within drug safety
- Impact of technology - learn and explore
- Explaining how to use the data sources and observational research for effective safety analysis
- Latest developments in pharmacovigilance, drug safety and risk management to ensure safer drugs to market
- Stay ahead of computing and electronic communications in pharmacovigilance
- Risk management plans
- Risk/benefit determinations
- Implications for safety reporting in global clinical trials
- Compliance and drug safety
- Training for drug safety - reporting duties, audits and expectations - risk based inspections
- Safety reporting in licensing agreement
- Good supply chain management practices for medicine distribution
- Accelerating new medicine introduction in developing world & overcoming challenges
- Analyzing the information on current industry projects and trends
- How will PV activities change with clinical trial transformation initiative?
- Recent successful strategies and business models to bring out new medicines
- Exploiting the pharmacy automations and technologies for enhancement of medication safety
- Determining the steps and strategies for enhancing quality in healthcare
- Improving patient care and safety in relation to use of medicines and all medical and paramedical interventions.
Key Speakers:
- Mazhar Maruf, Head of Pharmacovigilance, Glenmar
- Karthik Babu, Affiliate Pharmacovigilance Head, Sanofi
- Abhay Chimankar, Head - Global Drug Safety, Cipla
- Rahul Chauhan, Associate Director - Regulatory Affairs & Pharmacovigilance, Eli Lilly
- Abhay Phansalkar, Head - Medical Affairs, Wockhardt
- Bhaswat Chakraborty, Senior Vice President, Cadila
- Babita Kirodian, Head of Country Pharmacovigilance, Bristol Myers Squibb
- Manish Verma, Director Medical Affairs, Sanofi
- Indu Nambiar, Clinical Safety Officer, Boehringer Ingelheim
- Amit Arora, Head Medical Affairs, Merck Serono
- Manish Shah, General Manager, Global Clinical Operations, Wockhardt
- V K Sharma, Associate Vice President, Unichem Laboratories
- Girish Parhate, Senior Manager - Regulatory Affairs, Bayer
- Kamlesh Patel, GM, Medical Affairs & Pharmacovigilance, Abbott
- Milind Antani, Head - Pharma LifeSciences, Nishith Desai Associates
- Vandana Jolad Shivangi, Director, VIaTAL Pharma Consulting.
Plus Many More...
Target Audiance-Industry:-
- Pharmaceutical organisations
- Generic pharmaceutical companies
- Contract research organisations
- Patient recruitment companies
- Government- Department of health
- Non-profit organisations/ Association
- Consultans.
Who Should Attend:-
Vice Presidents, Directors, CRO's, Heads and Managers of:
- Pharmacovigilance Strategy
- Drug Safety/Risk Management
- Information and Clinical Data Management
- Clinical Research
- Research & Development
- Product Safety/Assurance Assessment
- Patient Safety & Outcomes Research & Data Analysis
- Epidemiology project management
- Regulatory Affairs and Compliance
- Sales & Marketing
- Biotech manufacturers.
Why Should You Attend:
Enjoy and make the best out of our dedicated networking drinks time,meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.
Conference Booking Details:
Early Bird Discounted Price - Conference Delegate Pass (INR 6,000 + Tax (12.36%) per delegate) - Book and Pay before 07th October 2014 to avail the early bird discounted price. You can simply email or call and book your conference delegate seats on TEL: + 91 7401150416. Email - nisha ( @ ) virtueinsight dot co dot in dot
Standard Price after early bird discounted time - 1 or 2 Delegates (INR 7,000 + Tax (12.36%) per delegate) - You can simply email or call and book your conference delegate seats on TEL: + 91 7401150416. Email - nisha ( @ ) virtueinsight dot co dot in dot
Group Discounts - 3 or 4 Delegates - (INR 6,500 + Tax (12.36%) per delegate)
Group Discounts - 5 and above Delegates - (INR 5,000 + Tax (12.36%) per delegate)
Spot Registration on the day of the conference - 1 Day Conference - (INR 8,000 + Tax (12.36%) per delegate)
Conference Sponsor & Exhibition Stall - Should you wish to Sponsor, or purchase a Exhibiton Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries to -TEL: + 91 7401150416. Email - nisha ( @ ) virtueinsight dot co.in.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam